JP2022551103A5 - - Google Patents

Info

Publication number
JP2022551103A5
JP2022551103A5 JP2022520605A JP2022520605A JP2022551103A5 JP 2022551103 A5 JP2022551103 A5 JP 2022551103A5 JP 2022520605 A JP2022520605 A JP 2022520605A JP 2022520605 A JP2022520605 A JP 2022520605A JP 2022551103 A5 JP2022551103 A5 JP 2022551103A5
Authority
JP
Japan
Prior art keywords
cells
pharmaceutical composition
composition according
timp
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520605A
Other languages
English (en)
Japanese (ja)
Other versions
JP7710242B2 (ja
JP2022551103A (ja
Filing date
Publication date
Priority claimed from GB201914235A external-priority patent/GB201914235D0/en
Application filed filed Critical
Publication of JP2022551103A publication Critical patent/JP2022551103A/ja
Publication of JP2022551103A5 publication Critical patent/JP2022551103A5/ja
Application granted granted Critical
Publication of JP7710242B2 publication Critical patent/JP7710242B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520605A 2019-10-02 2020-10-02 骨髄間葉系幹細胞由来細胞集団およびその調製方法 Active JP7710242B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1914235.5 2019-10-02
GB201914235A GB201914235D0 (en) 2019-10-02 2019-10-02 Cell populations and methods of preparing same
PCT/GB2020/052439 WO2021064424A1 (en) 2019-10-02 2020-10-02 Bone marrow mesenchymal stem cell derived cell populations and methods of preparing same

Publications (3)

Publication Number Publication Date
JP2022551103A JP2022551103A (ja) 2022-12-07
JP2022551103A5 true JP2022551103A5 (https=) 2023-10-10
JP7710242B2 JP7710242B2 (ja) 2025-07-18

Family

ID=68538920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520605A Active JP7710242B2 (ja) 2019-10-02 2020-10-02 骨髄間葉系幹細胞由来細胞集団およびその調製方法

Country Status (7)

Country Link
US (1) US20220389386A1 (https=)
EP (1) EP4038179B1 (https=)
JP (1) JP7710242B2 (https=)
KR (1) KR20220092880A (https=)
AU (1) AU2020361080A1 (https=)
GB (1) GB201914235D0 (https=)
WO (1) WO2021064424A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881707B (zh) * 2021-10-25 2023-07-14 中国人民解放军军事科学院军事医学研究院 调控脐带间充质干细胞免疫抑制作用的产品、方法及用途
CN117919220A (zh) * 2024-02-05 2024-04-26 南通大学附属医院 紫杉醇在制备促进肌腱细胞增殖药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009058983A2 (en) * 2007-10-30 2009-05-07 University Of Louisville Research Foundation, Inc. Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
WO2013067038A1 (en) * 2011-11-01 2013-05-10 Neostem, Inc. Adult mesenchymal stem cell (msc) compositions and methods for preparing the same
JP7168653B2 (ja) * 2017-08-16 2022-11-09 スンクワン メディカル ファウンデーション 間葉系幹細胞を含む甲状腺眼症を治療するための組成物

Similar Documents

Publication Publication Date Title
Saeed et al. Mesenchymal stem cells (MSCs) as skeletal therapeutics–an update
Jahanbin et al. Success of maxillary alveolar defect repair in rats using osteoblast-differentiated human deciduous dental pulp stem cells
Marbán et al. Heart to heart: cardiospheres for myocardial regeneration
WO2014082514A1 (zh) 一种启动哺乳动物干细胞的方法及二氧化氯在制备用于启动哺乳动物干细胞的药物的应用
JP2022551103A5 (https=)
Zou et al. Transplantation of collagen sponge-based three-dimensional neural stem cells cultured in a RCCS facilitates locomotor functional recovery in spinal cord injury animals
Cheng et al. Biocompatibility of polypropylene mesh scaffold with adipose-derived stem cells
TWI900599B (zh) 源自滑膜之間葉系幹細胞之製造方法及關節治療用細胞製劑之製造方法
RU2012140379A (ru) Способы и композиции для повышения срока выживаемости жирового трансплантата
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
KR101743488B1 (ko) 비피더스균 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물
EP3101121A1 (en) Odontogenic stem cells and use of genetically modified odontogenic stem cells
KR102889671B1 (ko) 인대 또는 건 질환의 예방, 개선 또는 치료용 조성물
WO2007048352B1 (en) Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
CN117778310B (zh) 一种脐带间充质干细胞的制备方法及其应用
JP6958847B1 (ja) 滑膜由来間葉系幹細胞の製造方法および関節治療用細胞製剤の製造方法
JP7474020B1 (ja) 歯髄幹細胞の培養上清の治療効果マーカー及び歯髄幹細胞の培養上清の判定方法および製造方法
WO2015085957A1 (zh) 治疗骨关节炎的组合物
CN105999416A (zh) 用于整形充填的自体脂肪与脐带间充质干细胞组合物
WO2013024312A1 (en) A pharmaceutical composition for the treatment of stem cells
CN105726571A (zh) 一种用于治疗椎间盘退行性变的脂肪间充质祖细胞复合物
Moh’d Said The Impact of Hydroxyapatite Nanoparticles on the Cellular Processes of Stem Cells Derived From Dental Tissue Sources
Antonijević et al. The role of mesenchymal stem cells in the therapy of myocardial infarction
Alexandrova et al. Briefly about mesenchymal stem cells-one of the main players in bone tissue engineering
EP2760449A1 (en) A pharmaceutical composition for the treatment of stem cells